Investor Acquires Stake in Bacil Pharma Ltd through Open Market Transaction
Niraj Rajnikant Shah has acquired a stake in Bacil Pharma Ltd through an open market purchase. The acquisition represents 6.44% of the company’s total share or voting capital.The transaction was completed by Niraj Rajnikant Shah, who holds no promoter status and is not part of any promoter group regarding the target company. Prior to the acquisition, Niraj Rajnikant Shah held zero shares in Bacil Pharma Ltd.
Acquisition Details
The details of the acquisition are as follows:| Metric | Value |
|---|---|
| Shares Acquired | 9,25,000 |
| Percentage of Total Share/Voting Capital | 6.44% |
| Mode of Acquisition | Open Market |
| Date of Acquisition | June 22, 2026 |
The purchase was made through the SSE Limited stock exchange. With this transaction, Niraj Rajnikant Shah's holding in Bacil Pharma Ltd stands at 6.44%.
Financial Capital Structure
The acquisition provides insight into the company’s capital structure both before and after the transaction. The total equity share capital of Bacil Pharma Ltd prior to the purchase was reported as Rs 14,35,30,000, representing 9,25,000 equity shares of Rs 10/- each.Following the acquisition, the company’s capital structure is defined by a total diluted share/voting capital of Rs 14,35,30,000, corresponding to 1,43,53,000 Equity Shares of Rs 10/- each.
Stock Price Movement
As of 11:07, Bacil Pharma Ltd sees shares ticking up at ₹40.90, reflecting a strong gain of 2.89%. The stock has navigated its intraday range today, trading between a low of ₹39.00 and an intraday high of ₹40.97.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.